Pulmonology Patient Flow Management

The Pulmonology Patient Mix and Why It Complicates Flow

Pulmonology practice patient flow is more complex than most subspecialty practices because the patient mix spans a wide range of clinical complexity, visit types, and ancillary service coordination requirements. A pulmonologist may see in a single afternoon session: a new consult for dyspnea requiring diagnostic workup planning, an established IPF patient for quarterly monitoring, a COPD patient requiring spirometry interpretation, a post-bronchoscopy follow-up, and a CPAP compliance check for an OSA patient.

Each of these visit types has different time requirements, different pre-visit preparation needs (labs, prior PFT results, CPAP data), and different ancillary coordination touchpoints. Scheduling them at the same default visit length — or failing to ensure pre-visit data is available — creates either rushed encounters or wasted time that accumulates into significant delays by afternoon.

The complexity distribution in a typical pulmonology practice: - New consultations: 15-25% of visit volume — highest complexity, longest duration (45-60 min), most pre-visit data requirements - Established disease management visits: 40-50% of volume — COPD, asthma, ILD, OSA, sarcoidosis, pulmonary hypertension — variable complexity (20-40 min) - PFT-integrated visits: 15-20% of volume — visits that include or immediately follow a PFT study — require coordination with the PFT lab schedule - Sleep medicine follow-ups: 10-15% of volume — CPAP compliance checks, sleep study result reviews, hypnotics management - Post-procedure follow-ups: 5-10% of volume — post-bronchoscopy, post-thoracentesis, post-BiPAP initiation

Understanding your practice's specific complexity distribution — by running a visit type analysis from your scheduling system — is the first step in redesigning visit templates and staffing ratios to match actual clinical demand.

New Consult Workflow: Getting the History Right the First Time

New pulmonology consultation is the highest-stakes visit in the practice from a diagnostic accuracy and patient experience perspective. A patient referred for unexplained dyspnea or abnormal CT finding has often waited 3-6 weeks for this appointment and arrives with anxiety and unmet information needs. A rushed 20-minute new consult that fails to capture the complete history will generate repeat visits, delayed diagnosis, and patient dissatisfaction.

New consult visit length standard: 45-60 minutes. This includes: - MA pre-encounter: medication reconciliation, vital signs, review of referring provider's documentation, prior spirometry or imaging results flagged for provider review — 10-12 minutes - Provider encounter: complete respiratory and relevant systemic history, physical exam (auscultation, percussion, respiratory pattern, extrapulmonary signs), review of imaging and prior PFT results, diagnostic impression, testing plan — 25-35 minutes - Post-encounter: order entry, consultation note completion, patient education, follow-up scheduling — 8-10 minutes

Pre-consultation data requirements — available before the provider enters the room: - CT chest report (if ordered by referring provider) — request from referring clinic or imaging center at time of appointment scheduling - Prior spirometry results (from any prior pulmonary evaluation) - Referring provider's note documenting the consultation question - Current medication list including inhalers and oxygen if applicable - Prior pulmonary hospitalizations (discharge summaries) if relevant

Practices that achieve 85%+ pre-visit data completion rates do so through a proactive data request process initiated at appointment booking — not the day before the visit. A dedicated clinical coordinator calls the referring practice within 48 hours of the referral to request the specific documents needed, with a follow-up 3 days before the appointment date.

Common failure mode: new consult scheduling without attached referral documentation results in the provider entering the room without the referring provider's note or prior imaging — requiring the entire diagnostic context to be reconstructed from patient self-report. This extends the new consult to 75-90 minutes and creates documentation inaccuracies.

PFT Integration Into Office Visit Flow

The coordination of PFT testing with office visits is a daily operational challenge in pulmonology. Three scheduling patterns emerge in practice, each with different efficiency and patient experience implications:

For this pattern to work, the PFT schedule must end at least 45 minutes before the office session begins — providing time for the tech to complete the report and the provider to review results before the patient is roomed. Practices that run PFT until 12:30 PM and start office visits at 1:00 PM routinely find the provider entering the room without reviewed PFT results.

Best practice recommendation: for new patients requiring a full PFT panel, use Pattern 2 (separate visit). For established COPD and asthma follow-ups requiring monitoring spirometry, use Pattern 3 if office spirometry equipment is available, or Pattern 1 with a morning PFT followed by an afternoon office visit.

Bronchoscopy Scheduling and Pre-Procedure Coordination

Flexible bronchoscopy and its variants (endobronchial ultrasound, EBUS-TBNA, navigational bronchoscopy) are the primary diagnostic and therapeutic procedures in pulmonology. Scheduling bronchoscopy requires coordination across the office scheduling system, the bronchoscopy suite (hospital-based or ASC), anesthesia or sedation services, pathology, and the post-procedure follow-up workflow.

Post-bronchoscopy follow-up scheduling: schedule a 2-week post-procedure office visit at the time of the bronchoscopy consent visit — not after the procedure results return. This ensures the patient has a scheduled touchpoint for result discussion regardless of the pathology turnaround time, and allows the pulmonologist to deliver results in person rather than by phone for significant diagnoses (suspected malignancy).

Bronchoscopy suite coordination: for hospital-based bronchoscopy, reserve block time on a specific day of the week (e.g., Thursday mornings). Dedicated block time prevents the ad hoc scheduling that results in procedures scattered across random days, making pre-procedure prep coordination and post-procedure follow-up scheduling inconsistent.

Sleep Medicine Coordination in the Pulmonology Practice

Many pulmonology practices have integrated sleep medicine as a subspecialty — managing OSA, central sleep apnea, obesity hypoventilation syndrome, and narcolepsy alongside traditional respiratory disease. The sleep medicine patient population requires distinct workflows for study ordering, CPAP initiation, compliance monitoring, and follow-up that must be integrated into the pulmonology clinic schedule without disrupting the respiratory disease visit flow.

Volume balance: in practices where sleep medicine comprises >30% of the practice volume, consider creating a dedicated sleep medicine schedule block separate from the respiratory disease schedule. Mixing a 60-minute new COPD consult back-to-back with a 15-minute CPAP compliance check creates scheduling inefficiency and makes accurate template design difficult.

Complex COPD Management Visits

Complex COPD management visits — for patients with GOLD Stage III-IV disease, frequent exacerbators, or patients being considered for advanced interventions — are the highest clinical intensity visits in pulmonology. These visits require comprehensive assessment of disease burden, medication optimization, exacerbation action planning, and coordination of multiple ancillary services.

Complex COPD visit assessment framework:

Symptom burden: mMRC dyspnea scale (0-4), CAT score (COPD Assessment Test, 0-40), activity limitation in ADLs, comparison to prior visit.

Exacerbation history: since last visit — number of exacerbations, severity (antibiotic only, oral steroid, ED visit, hospitalization), triggers identified, action plan adherence.

Peripheral eosinophil count: drawn at each complex COPD visit to guide ICS use decisions — eosinophil count ≥300 cells/μL supports ICS-containing therapy; <100 suggests ICS adds little benefit and increases pneumonia risk.

Advanced intervention assessment: for COPD patients with FEV1 <50%, significant hyperinflation (TLC >120% predicted), and preserved exercise tolerance, assess candidacy for bronchoscopic lung volume reduction (endobronchial valves — Zephyr, Spiration) or surgical referral for lung volume reduction surgery (LVRS) or lung transplant evaluation.

Document complex COPD visits with time-based billing when encounter time exceeds 40 minutes — CPT 99215 (40-54 minutes) with total time documented, including pre- and post-encounter coordination time.

Pulmonary Hypertension and Interstitial Lung Disease: High-Complexity Panels

Pulmonary hypertension (PH) and interstitial lung disease (ILD) represent the highest-complexity patient panels in pulmonology, with specialized monitoring requirements, expensive disease-modifying therapies, and frequent multi-specialty coordination needs. These patient populations require dedicated workflow infrastructure beyond the standard pulmonology visit template.

ILD monitoring workflow (distinct from PH): - Quarterly FVC monitoring in IPF and progressive fibrosing ILD - HRCT at 12-24 month intervals (depending on stability and clinical indication) - Coordination with rheumatology for CTD-ILD patients (RA-ILD, SSc-ILD, myositis-ILD) - Anti-fibrotic therapy management: nintedanib (monitor LFTs monthly × 3 months, then quarterly) and pirfenidone (monitor LFTs monthly × 6 months) - Lung transplant referral: IPF patients with FVC <80% predicted, DLCO <40% predicted, or ≥10% FVC decline in 12 months should be referred to a transplant center per ATS guidelines

Scheduling complexity: both PAH and ILD patients require longer visit slots (30-40 minutes for established, 60 minutes for new), pre-visit lab availability, and frequent between-visit communications. Allocate no more than 4-5 PAH or high-complexity ILD visits per session in a multi-provider practice to avoid documentation backlog.

Measuring Pulmonology Clinic Flow Performance

Pulmonology clinic flow improvement requires an operational measurement framework that distinguishes between visit-type-specific problems and systemic scheduling architecture problems. A practice where new consults consistently run over time has a different root cause than a practice where CPAP compliance visits create a mid-afternoon backup.

Pulmonology-specific flow metrics to track weekly:

New consult completion rate: percentage of new consultations where the consultation note is finalized and transmitted to the referring provider within 3 business days. Target: 95%. Below 85% indicates documentation architecture issues or insufficient post-visit completion time built into the schedule.

PFT same-day coordination success rate: when a same-day PFT + office visit is scheduled, what percentage of the time is the PFT report available before the provider enters the office visit room? Target: 90%. Below 80% indicates a PFT-to-office visit scheduling gap that must be resolved by adding time between PFT session end and office visit start.

Pre-visit data completeness rate: percentage of new consults where the referring provider's note and prior imaging/PFT results are available in the chart before the appointment. Target: 80%. Below 70% indicates the data request process initiated at scheduling is failing — typically because the call is made too late (day before rather than at booking).

Bronchoscopy prior auth approval rate: percentage of bronchoscopy authorizations approved on first submission. Target: 85%+. Below 80% indicates documentation gaps in auth submissions for specific payers or procedure types.

Post-bronchoscopy follow-up scheduling rate: percentage of bronchoscopy patients who have a follow-up appointment scheduled at the time of the procedure. Target: 100%. Any value below 100% represents patients who will receive pathology results without a structured result discussion appointment — a clinical and patient experience risk.

Sleep medicine CPAP compliance visit rate: percentage of CPAP-initiated patients who return for 30-90 day compliance visit within the Medicare-required window. Target: 90%+. Below 80% represents patients at risk of losing Medicare CPAP coverage and requires proactive recall outreach.